Cholecystitis treatment typically involves a combination of pain control, antibiotics for infection, and in many cases surgery to remove the gallbladder. Medications alone rarely cure the underlying problem, but they play a critical role at every stage: easing the acute misery of a gallbladder attack, preventing sepsis while you wait for or recover from an operation, and in select patients, slowly dissolving the gallstones that caused trouble in the first place. The specific drugs your doctor reaches for depend on how sick you are, which bacteria are involved, and whether surgery is even an option.
Pain Relief in Acute Cholecystitis
The first thing most people want when a gallbladder attack hits is relief from the intense right-upper-quadrant pain. Anti-inflammatory drugs like diclofenac, ketorolac, and ibuprofen are the usual first-line choices. A meta-analysis found that NSAIDs controlled biliary pain better than antispasmodic drugs and performed comparably to opioids.1PubMed. Meta-analysis: nonsteroidal anti-inflammatory drugs in biliary colic A separate systematic review reached a similar conclusion, finding no clear difference in pain relief between NSAIDs and opioids, though the evidence quality was low.2Annals of Emergency Medicine. Are Nonsteroidal Anti-inflammatory Drugs Efficacious in Relieving Biliary Colic Pain?
NSAIDs have an advantage beyond simple pain relief. Inflamed gallbladder tissue churns out prostaglandins at several times the normal rate, and those prostaglandins drive fluid secretion and swelling inside the gallbladder wall.3Hepatology. Human Cholecystitis Is Associated With Increased Gallbladder Prostaglandin I2 and Prostaglandin E2 Synthesis By blocking prostaglandin production, NSAIDs attack the inflammation itself, not just the pain signal. Animal studies show that indomethacin can reverse the drop in gallbladder fluid absorption that inflammation causes, at least in the early hours.4Gastroenterology. The role of prostaglandin I2 and biliary lipids during evolving cholecystitis in the rabbit Once the inflammation has been going on for a day or more, though, changes in bile chemistry take over and the anti-prostaglandin effect of NSAIDs becomes less helpful.
Why Opioids Are Used Cautiously
Opioids are sometimes necessary when NSAIDs are contraindicated or when pain is severe, but they come with a well-known wrinkle in biliary disease. All opioids raise pressure in the sphincter of Oddi, the muscular valve where the bile duct empties into the small intestine. Morphine causes the largest pressure spike, and even meperidine (once thought to be safer for biliary pain) measurably tightens the sphincter at clinical doses.5PubMed. Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis In a study of patients with postcholecystectomy pain, morphine injection reproduced their symptoms in parallel with rising bile duct pressure.6PubMed Central. Manometric diagnosis of sphincter of Oddi spasm as a cause of postcholecystectomy pain and the treatment by endoscopic sphincterotomy In practice, many emergency departments still use low-dose hydromorphone or fentanyl when an NSAID alone is not enough, but morphine specifically tends to be avoided.
Antibiotics and the Bacteria They Target
Mild cholecystitis that heads straight to the operating room within a day or two may not need antibiotics at all. But moderate and severe cases do, because bacteria in the bile can seed the bloodstream and cause sepsis. The decision to start antibiotics, and which ones to pick, hinges on how sick you are, whether the infection started in the community or a hospital, and local resistance patterns.7PubMed Central. Updates on Antibiotic Regimens in Acute Cholecystitis
What Is Actually Growing in an Infected Gallbladder
The bugs most commonly pulled from infected bile are gram-negative rods from the gut. In a large tertiary-hospital study, Escherichia coli accounted for about 40% of gram-negative isolates, followed by Klebsiella pneumoniae at roughly 16% and Pseudomonas aeruginosa at about 12%.8PubMed Central. Epidemiological, clinical and microbiological characteristics of patients with biliary tract diseases with positive bile culture in a tertiary hospital A separate prospective study of patients with moderate or severe cholecystitis found bacteria or fungi in 86% of bile samples when advanced sequencing was used, but standard culture missed most of the diversity, detecting only about 38% of the organisms present. Oral streptococci, anaerobes, and enterococci were frequently identified by sequencing yet missed by culture.9PubMed. Bacteria and fungi in acute cholecystitis. A prospective study comparing next generation sequencing to culture
Blood cultures turn positive less often than bile cultures. In one series of over 250 patients, bile grew bacteria in about half of cases, while blood cultures were positive in only about 15%.10PubMed. The Bacteriology of Acute Cholecystitis: Comparison of Bile Cultures and Clinical Outcomes in Diabetic and Non-Diabetic Patients That gap matters because empirical antibiotics are chosen before cultures come back. The initial regimen has to cover the most likely gram-negative organisms and, in sicker patients, anaerobes and enterococci as well.
Which Antibiotics Are Chosen and Why
International guidelines, including the widely referenced Tokyo Guidelines, stratify antibiotic recommendations by severity grade. For community-acquired mild to moderate cholecystitis, a second- or third-generation cephalosporin or a fluoroquinolone with metronidazole is often sufficient. Severe or healthcare-associated infections may call for broader agents such as piperacillin-tazobactam or a carbapenem.11PubMed. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis Once culture results are in, guidelines recommend narrowing to the most targeted effective agent.
An antibiotic’s ability to penetrate bile and gallbladder tissue influences its effectiveness. A review of pharmacokinetic data found that most antibiotic classes reach therapeutic concentrations in bile, but a handful do not. Amoxicillin, certain first-generation cephalosporins, ertapenem, aminoglycosides like gentamicin and amikacin, and trimethoprim-sulfamethoxazole all showed poor biliary penetration.12PubMed. Antibiotics in the Biliary Tract: A Review of the Pharmacokinetics and Clinical Outcomes of Antibiotics Penetrating the Bile and Gallbladder Wall On the other hand, moxifloxacin concentrated in gallbladder tissue at roughly two to six times the simultaneous blood level in patients undergoing cholecystectomy, making it a reasonable option for biliary infections.13Journal of Antimicrobial Chemotherapy. Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections
How Long to Continue Antibiotics
Shorter is generally better. The Surgical Infection Society recommends against post-operative antibiotics for patients who undergo laparoscopic cholecystectomy for mild or moderate cholecystitis. Even for severe cases, the guideline caps treatment at four days after surgery, and possibly shorter.14PubMed. Surgical Infection Society Guidelines for Antibiotic Use in Patients Undergoing Cholecystectomy for Gallbladder Disease A study specifically examining post-operative antibiotic duration confirmed that extending treatment beyond four days after early cholecystectomy provided no additional reduction in wound infections.15Journal of Gastrointestinal Surgery. Optimal duration of postoperative or conservative antibiotic therapy in acute cholecystitis Overusing antibiotics after source control (gallbladder removal) mainly breeds resistance without benefiting the patient.
Gallstone Dissolution With Ursodeoxycholic Acid
Most cholecystitis is caused by gallstones, and one of the few medications that can dissolve gallstones is ursodeoxycholic acid, or UDCA. It works by shifting bile chemistry: reducing cholesterol secretion into bile by roughly 40 to 60% and increasing the conversion of cholesterol into bile acids, which makes the bile less prone to forming crystals.16Journal of Translational Gastroenterology. A Review of Ursodeoxycholic Acid Therapy for Cholelithiasis and Choledocholithiasis UDCA has been studied since the late 1970s. An early placebo-controlled trial achieved stone dissolution in about a quarter of treated patients over several months, with no sign of liver toxicity.17PubMed. Dissolution of cholesterol gallstones by ursodeoxycholic acid
Head-to-head comparisons with the older bile acid chenodeoxycholic acid (CDCA) found UDCA to be more effective in the first six months and better tolerated, since CDCA frequently caused diarrhea and liver enzyme elevations that UDCA did not.18PubMed. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study Even so, UDCA is not a first-line treatment for most people with gallstone cholecystitis. It only works on cholesterol stones (not pigment stones), works best on small stones, requires months of daily dosing, and stones frequently recur after the drug is stopped. Surgery remains the definitive fix.
UDCA for Preventing Stones After Weight Loss Surgery
One area where UDCA has carved out a strong niche is preventing gallstones after bariatric surgery. Rapid weight loss dramatically increases gallstone risk, and randomized trials have shown that UDCA taken during the period of fastest weight loss cuts that risk significantly. In a multicenter placebo-controlled trial, gallstones formed in about 32% of placebo patients over six months compared with just 2% of patients taking 600 mg of UDCA daily.19PubMed. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss A narrative review of this literature confirmed that effective doses ranged from 500 to 1,200 mg daily, typically taken for the first three to six months after bariatric surgery.20PubMed Central. Prevention of Gallstones After Bariatric Surgery using Ursodeoxycholic Acid: A Narrative Review of Literatures
A larger and more recent trial added nuance. When all bariatric surgery patients were pooled together, UDCA did not quite reach statistical significance in preventing symptomatic gallstone disease. But in the subgroup who had no gallstones before their operation, UDCA cut the risk roughly in half. Patients who already had asymptomatic stones at baseline saw no benefit.21The Lancet Gastroenterology & Hepatology. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE) The practical takeaway: UDCA prevents new stone formation during rapid weight loss but does not make pre-existing stones less dangerous.
When Surgery Is Not an Option
Cholecystectomy is the standard treatment for acute cholecystitis, but not everyone can have surgery. Elderly patients, people with severe heart or lung disease, and critically ill ICU patients may be too unstable for an operation. In those situations, treatment is entirely medical: antibiotics, pain management, nothing by mouth, and intravenous fluids. A pooled analysis of studies on conservative treatment found an initial success rate of about 86%, but roughly one in five patients went on to develop recurrent gallstone problems.22PubMed. Conservative treatment of acute cholecystitis: a systematic review and pooled analysis
For patients who fail conservative management but still cannot undergo cholecystectomy, percutaneous cholecystostomy is an option. A radiologist places a small drain through the skin into the gallbladder to decompress it. Studies in high-risk elderly patients have confirmed that this procedure can relieve symptoms quickly when surgery is contraindicated.23PubMed Central. The Efficacy of Percutaneous Transhepatic Gallbladder Drainage on Acute Cholecystitis in High-Risk Elderly Patients Based on the Tokyo Guidelines However, the long-term picture is sobering. In a cohort study, nearly 39% of patients managed with cholecystostomy were readmitted for gallstone-related problems, and about a quarter had a recurrence of cholecystitis itself.24PubMed. Percutaneous Cholecystostomy Versus Conservative Treatment for Acute Cholecystitis: a Cohort Study These approaches buy time and reduce immediate danger, but they do not solve the underlying problem the way removing the gallbladder does.
A newer option for patients who cannot tolerate surgery or a percutaneous drain is endoscopic gallbladder drainage, where a stent is placed through the gastrointestinal tract wall directly into the gallbladder under ultrasound guidance. This avoids having an external drain and the infection and dislodgement risks that come with it.25PubMed Central. Recent advances in management of acalculous cholecystitis It is still relatively new and available mainly at specialized centers, but it is expanding the toolbox for high-risk patients.
Cholecystitis in Pregnancy
Pregnant patients with acute cholecystitis present a distinct challenge because the list of safe medications shrinks, and there is a second patient to protect. NSAIDs are generally avoided in the third trimester because of risks to the fetal heart and kidneys, so pain management often leans more heavily on acetaminophen or carefully dosed opioids. Antibiotics must be chosen from pregnancy-safe categories, which rules out fluoroquinolones and tetracyclines. In one series from a developing-country center, all patients with cholecystitis during pregnancy received intravenous antibiotics, and about two-thirds ultimately underwent laparoscopic cholecystectomy during the pregnancy. Tocolysis (medications to prevent preterm labor) was needed in a majority of those patients, underscoring how the gallbladder inflammation itself can irritate the uterus.26PubMed Central. Acute cholecystitis in pregnant women: A therapeutic challenge in a developing country center The trend in surgical practice has shifted toward operating during pregnancy when cholecystitis is clearly acute, rather than delaying until after delivery, because repeated flares carry their own risks of preterm birth and complications.
When Medications Themselves Cause Gallbladder Trouble
Some drugs can paradoxically trigger the very problem they are not meant to treat. Ceftriaxone, a widely used intravenous antibiotic, is the best-documented offender. When ceftriaxone concentrations in bile rise high enough, the drug binds to calcium ions and precipitates into sludge or stone-like deposits. These are sometimes called biliary pseudolithiasis because they look like gallstones on ultrasound but are made of calcium-ceftriaxone complexes rather than cholesterol or bilirubin.27PubMed Central. A case of ceftriaxone-associated biliary pseudolithiasis in an elderly patient with renal dysfunction
The phenomenon is not rare. A prospective study comparing ceftriaxone with cefotaxime (a related antibiotic that is excreted differently) in children found abnormal gallbladder ultrasound findings in about 21% of ceftriaxone-treated patients versus roughly 6% of those on cefotaxime. Actual stone-like deposits appeared in about 15% of the ceftriaxone group.28PubMed. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children In most cases these deposits dissolve after the drug is stopped, but in vulnerable patients they can trigger genuine cholecystitis. A case report documented acute necrotizing cholecystitis in an elderly man after six days of ceftriaxone. Infrared analysis of the extracted gallstones matched the spectral pattern of ceftriaxone powder, confirming the drug as the culprit. The authors identified older age, dehydration, fasting, and prolonged bed rest as compounding risk factors.
Awareness of this side effect matters because ceftriaxone is one of the most commonly prescribed intravenous antibiotics worldwide. If a patient on ceftriaxone develops new right-upper-quadrant pain and gallbladder sludge on imaging, the first step is usually to stop the drug and switch to an alternative rather than rushing to surgery. In many cases the sludge clears on its own within weeks.
Acalculous Cholecystitis and How Its Treatment Differs
About 5 to 10% of cholecystitis cases occur without any gallstones at all. This acalculous form typically strikes critically ill patients in the ICU: people on ventilators, after major trauma or surgery, or with severe burns. Because there is no stone to blame, the inflammation is thought to result from gallbladder ischemia and bile stasis in an already compromised patient. The medication strategy is the same as for calculous cholecystitis (antibiotics, pain control, supportive care), but the source-control options are different. Since there are no stones to dissolve and these patients are often too unstable for cholecystectomy, percutaneous drainage or the newer endoscopic stent approach becomes the main intervention.29PubMed Central. Recent advances in management of acalculous cholecystitis Mortality rates for acalculous cholecystitis are considerably higher than for the stone-related form, largely because the patients who develop it are already very sick.
Emerging and Investigational Approaches
UDCA remains the only well-established gallstone-dissolving drug, but researchers are exploring ways to make it work better and investigating entirely new approaches. One challenge with UDCA is that it dissolves poorly in water, which limits how much the body actually absorbs. Work on nanoparticle and novel formulation strategies aims to improve its bioavailability. Beyond bile acids, early-stage research has looked at agents like alirocumab (a cholesterol-lowering injectable already approved for cardiovascular use), probiotics that might alter bile composition, and various herbal extracts with purported stone-dissolving properties. None of these have reached the stage of large clinical trials for gallstone disease, and none are currently part of standard cholecystitis management. For the foreseeable future, UDCA for select stone dissolution and prevention after bariatric surgery, NSAIDs for pain, and targeted antibiotics for infection remain the medication pillars, while cholecystectomy continues to be the definitive cure.